Delivery Order SPE2DB20D3103-SPE2DB24FM5E7
- Not listed
- This federal contract award is for the delivery of the pharmaceutical product Wegovy (2.4 mg/0.75 ml pen, 0.75 ml) to the Defense Logistics Agency (DLA). The $89,389.47 firm-fixed-price delivery order was awarded on May 12, 2023 to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of May 15, 2023 and was not set aside for any specific business category. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- This federal contract award is for the delivery of Wegovy 2.4 mg/0.75 ml pens to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $30,887.36, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a completion date of February 22, 2024 and is a firm fixed-price delivery order. There is no set-aside designation for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves...
- This federal contract award is for the delivery of the pharmaceutical product Wegovy 0.5 mg/0.5 ml pen 0.5 ml to the Defense Logistics Agency (DLA). The $1,187.46 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
- This contract award is for the pharmaceutical product Wegovy 1.7 mg/0.75 ml pen, awarded by the Defense Logistics Agency (DLA) to prime contractor Amerisourcebergen Drug Corp. The contract has a ceiling value of $7,679.56 and a completion date of July 27, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor that provides a wide range of medical supplies and pharmaceuticals to federal government agencies, particularly...
- This federal contract award is for the delivery of Wegovy 1 mg/0.5 ml pens to the Defense Logistics Agency (DLA), a defense agency. The firm-fixed-price delivery order has a ceiling value of $1,277.33 and an ultimate completion date of July 3, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. This award is not set-aside and represents an open competition. Amerisourcebergen Drug Corp...
- This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The award, valued at $1,097.08, is for the delivery of the drug Wegovy 0.5 mg/0.5 ml pen 0.5 ml. The contract is a Delivery Order with a Firm Fixed Price pricing type, awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of April 26, 2024....
- This federal contract award is for the delivery of Wegovy 0.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA) Medical Supply Chain. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $18,991.83. The contract is a delivery order with firm fixed pricing and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,418.76, is a delivery order for the drug Wegovy 2.4 mg/0.75 ml pen 0.75 ml. The contract has a period of performance ending on March 13, 2024 and is a firm-fixed-price contract. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a key vendor for federal healthcare programs,...
- This federal contract award is for the delivery of Wegovy 2.4 mg/0.75 ml pens to the Defense Logistics Agency (DLA). The contract, valued at $2,266.12, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with a completion date of May 2, 2023. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,376.21, is for the delivery of the drug Wegovy 2.4 mg/0.75 ml pen 0.75 ml. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 15, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FM5E7Delivery Order
This federal contract award is for the delivery of the pharmaceutical product Wegovy 1 mg/0.5 ml pen, 0.5 ml. The contract, valued at $2,194.16, was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order, with a completion date of February 2, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This award is not designated as a set-aside contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 2/1/24 |